Supplier News Breaks Archives
Perrigo launches Neptazane generic
March 12th, 2014
DUBLIN, Ireland – Perrigo Co. has released methazolamide tablets, a medication for glaucoma, through a distribution and supply agreement.
The company said Wednesday that the new product is a generic equivalent of Neptazane tablets from Fera Pharmaceuticals.
Perrigo reported that the new generic is a component of the contingent rights that the company received via its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals LLC and its affiliates last June.
Methazolamide tablets are indicated for the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma and secondary glaucoma, as well as preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery, according to Perrigo. Estimated annual sales are about $12 million, the company said.
"This launch reflects our continuing investment in new products," Perrigo chairman and chief executive officer Joseph Papa stated, adding that the new generic is "a great addition to the portfolio of ophthalmic products Perrigo is marketing today."